Start Your NewsReadery Pro FREE TRIAL!
Register and verify your email address to start your
NewsReadery Pro FREE TRIAL
today!
Login / Register
Actions
Newsfeed
Popular
Local
Discover
Follows
Blocks
Bookmarks
Filters
Settings
PowerUps
Help
Updates
Login / Register
stocktitan.net
/
Share Newsitem
View, share or embed this newsitem using the details below.
Stock Market News Live | StockTitan.net
@stocktitan.net
/
5 hours
5h
Follow
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Shuttle Pharmaceuticals secures $4.5M through public offering to advance cancer drug trials, with $2.3M allocated for Phase II testing of Ropidoxuridine. Learn how this strategic funding impacts drug development timelines.
https://newsreadery.com/go/e9ed57c2199d4630fc52057381c2f8df
Save
Share
Share this Newsitem URL
Embed this Newsitem
<div class="readery-embed readery-embed-e9ed57c2199d4630fc52057381c2f8df"></div><script async src="https://open.newsreadery.com/oembed?format=html&url=https%3A%2F%2Fnewsreadery.com%2Fitem%2Fe9ed57c2199d4630fc52057381c2f8df" charset="utf-8"></script>
Back
Read Full Article
Continue
Please wait ...